Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$724
+$21 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,133
of 3,139 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2026CallValue
$4,091,956
CallShares
11,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $5,014,937 across 4 Drug Manufacturers - General names. AMGN ranks #4 (0.0% of the industry book) .
All Filings in AMGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,091,956 | 11,300 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $724 | 2 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $68,505,195 | 194,700 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $703 | 2 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $12,666,897 | 38,700 | Put | Defined | 2026-03-12 | |
| 2025-12-31 | $101,597,024 | 310,400 | Call | Defined | 2026-03-12 | |
| 2025-09-30 | $862,403 | 3,056 | Shares | Defined | 2026-03-31 | |
| 2025-09-30 | $1,523,880 | 5,400 | Call | Defined | 2026-03-31 | |
| 2025-09-30 | $9,510,140 | 33,700 | Put | Defined | 2026-03-31 | |
| 2025-03-31 | $15,546,345 | 49,900 | Put | Defined | 2025-05-14 | |
| 2025-03-31 | $50,782,650 | 163,000 | Call | Defined | 2025-05-14 | |
| 2025-03-31 | $623 | 2 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,563,504 | 121,100 | Call | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||